Insulin Inhaler Wins FDA Approval
After
a decade-long quest to develop an inhalable form of insuling for
diabetics, billionaire-inventor Alfred Mann finally won approval from
the FDA. On Friday, his company, MannKind Corp, was given the all clear to proceed with their drug named 'Afrezza'.
Diabetes is a chronic condition in
which the body either does not use insulin efficiently or fails to make
enough insulin to break down the sugar in foods. Such a problem can
cause blindness, heart disease, strokes and ultimately death. Type 2
diabetes is the most common form of the disease. It is where the body is
unable to use insulin properly. Type 1 diabetes is most often diagnosed
in children and young adults. This is where the body does not produce
insulin.
The FDA cleared this drug for use by
type I and type II diabetics. The inhaler will be used to help control
blood-sugar levels during meals. Instead of the painful and unpleasant
injection most diabetes patients have to go through today, a quick puff
before the meal will do the trick.
The FDA also warns that patients with
asthma or chronic obstructive pulmonary disease should avoid this drug,
as it may cause airway complications for them.
This drug, says the FDA, is not a
replacement for long acting insulin. Diabetics would still need to get
an injection from time to time. But on a day to day basis, before meals,
these patients will be able to take a quick inhalation instead of an
injection. And as most of them will surely tell you - that is a world of
difference.
The inhalant is to be taken at the
beginning of each meal or at least 20 minutes after the diabetic has
begun eating. Top insulin levels, according to MannKind Copr, will occur
within 12-15 minutes after inhaling Afrezza. This in comparison with
the 45-90 minutes it takes with the injected insulin.
There are about 30 million diabetics
in the US alone. Worldwide, diabetes has become a pandemic, with demand
for more effective treatments rising every year. This solution
represents one of many diabetes treatments currently fighting for
approval. It is my hope that it is the first of many truly effective
treatments we will see hitting the market this coming decade.
Labels: inhaler, insulin injections, Type 1 diabetes, type 2 diabetes
0 Comments:
Post a Comment
<< Home